The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.
 
Michelle Pek
Employment - Lucence Diagnostics
Consulting or Advisory Role - Lucence
 
Hao Chen
Employment - Lucence Diagnostics
Leadership - Lucence Diagnostics
 
Zi Yi Wan
Employment - Lucence Diagnostics
 
Kao Chin Ngeow
Employment - Lucence Diagnostics
Patents, Royalties, Other Intellectual Property - Inventorship for patents relating to diagnostics technologies filed by employer.
 
Boon C. Goh
Stock and Other Ownership Interests - Gilead Sciences; Regeneron
Honoraria - Amgen; MSD Oncology; Novartis
Consulting or Advisory Role - Adagene; Bayer; Otsuka
Research Funding - Adagene (Inst); ALX Oncology (Inst); Bayer; Bristol-Myers Squibb/Medarex (Inst); Genentech/Roche; Kyowa Hakko Kirin; MSD Oncology (Inst)
 
Siu Kie Au
No Relationships to Disclose
 
Wai Meng David Tai
Honoraria - Bristol-Myers Squibb; Eisai
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Roche
Research Funding - Bristol-Myers Squibb; Novartis; Sirtex Medical
 
Joycelyn Jie Xin Lee
Consulting or Advisory Role - Bayer; Ipsen
Research Funding - Bayer (Inst)
 
Zi Yi Lim
No Relationships to Disclose
 
Iain B. Tan
No Relationships to Disclose
 
Dawn Q Chong
No Relationships to Disclose
 
Chwee Ming Lim
No Relationships to Disclose
 
Ravindran Kanesvaran
No Relationships to Disclose
 
SuPin Choo
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Honoraria - AstraZeneca; BMS; Eisai; Ipsen; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD Oncology; Roche; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Taiho Pharmaceutical
 
Min-Han Tan
Employment - Lucence Diagnostics
Leadership - Lucence Diagnostics
Stock and Other Ownership Interests - Lucence Diagnostics
Patents, Royalties, Other Intellectual Property - Drug delivery technology, diagnostics technology